Association of single nucleotide polymorphisms in IL-12 and IL-27 genes with colorectal cancer risk

Clinical Biochemistry

Volumn 45, Issue 1-2, 2012, Pages 54-59

  Huang, Zhao Quan ^a   Wang, Jun Li ^a,b   Pan, Guo Gang ^a   Wei, Ye Sheng ^a,b  

^a AFFILIATED HOSPITAL OF YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITIES   (China)

^b YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITIES   (China)

Author keywords

Colorectal cancer risk; Haplotypes; IL 12 and IL 27 genotypes

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 27;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CASE-CONTROL STUDIES; CHINA; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HAPLOTYPES; HUMANS; INTERLEUKIN-12; INTERLEUKIN-17; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84855297435     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.10.004     Document Type: Article

References (51)

1. Velculescu V.E. Defining the blueprint of the cancer genome. Carcinogenesis 2008, 29:1087-1091.
2. Kim H.J., Yu M.H., Kim H., Byun J., Lee C. Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 2008, 41:685-692.
3. Gallagher D.J., Smith J.D., Offit K., Papadopoulos C., Stadler Z., Weiser M.R., et al. Diagnosing hereditary colorectal cancer. Clin Colorectal Cancer 2010, 9:205-211.
4. Cheah P.Y. Recent advances in colorectal cancer genetics and diagnostics. Crit Rev Oncol Hematol 2009, 69:45-55.
5. Chu E. Clinical colorectal cancer: "2008-the year in review" Clin Colorectal Cancer 2009, 8:9-10.
6. Del Vecchio M., Bajetta E., Canova S., Lotze MT, Wesa A, Parmiani G, et al. Interleukin-12: biological properties and clinical application. Clin Cancer Res 2007, 13:4677-4685.
7. Emoto Y., Yoshizawa I., Hurwitz R., Brinkmann V, Kaufmann SH, Emoto M Role of interleukin-12 in determining differential kinetics of invariant natural killer T cells in response to differential burden of Listeria monocytogenes. Microbes Infect 2008, 10:224-232.
8. Zabala M., Lasarte J.J., Perret C., Sola J, Berraondo P, Alfaro M, et al. Induction of immunosuppressive molecules and regulatory T cells counteracts the antitumor effect of interleukin-12-based gene therapy in a transgenic mouse model of liver cancer. J Hepatol 2007, 47:807-815.
9. Murakami S., Okubo K., Tsuji Y., Sakata H, Hamada S, Hirayama R Serum interleukin-12 levels in patients with gastric cancer. Surg Today 2004, 34:1014-1019.
10. Sangro B., Melero I., Qian C., Prieto J Gene therapy of cancer based on interleukin 12. Curr Gene Ther 2005, 5:573-581.
11. He X.Z., Wang L., Zhang Y.Y. An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells. World J Gastroenterol 2008, 14:532-540.
12. Stanilova S., Miteva L., Prakova G. Interleukin-12B-3'UTR polymorphism in association with IL-12p40 and IL-12p70 serum levels and silicosis severity. Int J Immunogenet 2007, 34:193-199.
13. Windsor L., Morahan G., Huang D., McCann V, Jones T, James I, et al. Alleles of the IL12B 3'UTR associate with late onset of type 1 diabetes. Hum Immunol 2004, 65:1432-1436.
14. Han S.S., Cho E.Y., Lee T.S., Kim J.W., Park N.H., Song Y.S., et al. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical cancer in Korean women. Eur J Obstet Gynecol Reprod Biol 2008, 140:71-75.
15. Hunter C.A. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005, 5:521-531.
16. Trinchieri G., Pflanz S., Kastelein R.A. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003, 19:641-644.
17. Chiyo M., Shimozato O., Yu L., Kawamura K., Iizasa T., Fujisawa T., et al. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 2005, 115:437-442.
18. Chae S.C., Li C.S., Kim K.M., Yang J.Y., Zhang Q., Lee Y.C., et al. Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. J Hum Genet 2007, 52:355-361.
19. John S.W., Weitzner G., Rozen R., Scriver C.R. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res 1991, 19:408.
20. Wei Y.S., Lan Y., Luo B., Lu D., Nong H.B. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Mol Carcinog 2009, 48:751-757.
21. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
22. Stephens M., Smith M.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
23. Ikeda Y., Yoshida W., Noguchi T., Asaba K., Nishioka T., Takao T., et al. Lack of association between IL-12B gene polymorphism and autoimmune thyroid disease in Japanese patients. Endocr J 2004, 51:609-613.
24. Yang J.M., Nagasaka S., Yatagai T., Nakamura T., Kusaka I., Ishikawa S.E., et al. Interleukin-12p40 gene (IL-12B) polymorphism and Type 1 diabetes mellitus in Japanese: possible role in subjects without having high-risk HLA haplotypes. Diabetes Res Clin Pract 2006, 71:164-169.
25. Yanagihori H., Tojo M., Inoue T., Nakamura K., Kaneko F., Nishida T., et al. Lack of association of interleukin-12 p40 gene (IL12B) polymorphism with Behçet's disease in the Japanese population. J Dermatol Sci 2004, 34:112-114.
26. Tsunemi Y., Saeki H., Nakamura K., Sekiya T., Hirai K., Fujita H., et al. Interleukin-12 p40 gene (IL12B) 3'-untranslated region polymorphism is associated with susceptibility to atopic dermatitis and psoriasis vulgaris. J Dermatol Sci 2002, 30:161-166.
27. Sánchez E., Morales S., Paco L., López-Nevot M.A., Hidalgo C., Jiménez-Alonso J., et al. Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus. Rheumatology (Oxford) 2005, 44:1136-1139.
28. Latsi P., Pantelidis P., Vassilakis D., Sato H., Welsh K.I., du Bois R.M. Analysis of IL-12 p40 subunit gene and IFN-gamma G5644A polymorphisms in idiopathic pulmonary fibrosis. Respir Res 2003, 4:1-5.
29. Nisticò L., Giorgi G., Giordano M., Galgani A., Petrone A., D'Alfonso S., et al. IL12B polymorphism and type 1 diabetes in the Italian population: a case-control study. Diabetes 2002, 51:1649-1650.
30. Seegers D., Zwiers A., Strober W., Peña A.S., Bouma G. A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002, 3:419-423.
31. Hall M.A., McGlinn E., Coakley G., Fisher S.A., Boki K., Middleton D., et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 2000, 1:219-224.
32. Orozco G., González-Gay M.A., Paco L., López-Nevot M.A., Guzmán M., Pascual-Salcedo D., et al. Interleukin 12 (IL12B) and interleukin 12 receptor (IL12RB1) gene polymorphisms in rheumatoid arthritis. Hum Immunol 2005, 66:710-715.
33. Lu H., Ouyang W., Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 2006, 4:221-233.
34. Moss S.F., Blaser M.J. Mechanisms of disease: inflammation and the origins of cancer. Nat Clin Pract Oncol 2005, 2:90-97.
35. Quirk J.T., Kupinski J.M. Chronic infection, inflammation, and epithelial ovarian cancer. Med Hypotheses 2001, 57:426-428.
36. Lin W.W., Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007, 117:1175-1183.
37. Sugiyama Y., Kato M., Chen F.A., Williams S.S., Kawaguchi Y., Miya K., et al. Human inflammatory cells within the tumor microenvironment of lung tumor xenografts mediate tumor growth suppression in situ that depends on and is augmented by interleukin-12. J Immunother 2001, 24:37-45.
38. Weiss J.M., Subleski J.J., Wigginton J.M., Wiltrout R.H. Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther 2007, 7:1705-1721.
39. Horinaga M., Harsch K.M., Fukuyama R., Heston W., Larchian W. Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model. Urology 2005, 66:461-466.
40. You T.G., Wang H.S., Yang J.H., Qian Q.J., Fan R.F., Wu M.C. Transfection of IL-2 and/or IL-12 genes into spleen in treatment of rat liver cancer. World J Gastroenterol 2004, 10:2190-2194.
41. Muta M., Matsumoto G., Hiruma K., Nakashima E., Toi M. Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model. Oncol Rep 2003, 10:1765-1769.
42. Villarino A.V., Huang E., Hunter C.A. Understanding the pro- and anti-inflammatory properties of IL-27. J Immunol 2004, 173:715-720.
43. Owaki T., Asakawa M., Morishima N., Hata K., Fukai F., Matsui M., et al. A role for IL-27 in early regulation of Th1 differentiation. J Immunol 2005, 175:2191-2200.
44. Hölscher C., Hölscher A., Rückerl D., Yoshimoto T., Yoshida H., Mak T., et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 2005, 174:3534-3544.
45. Cordoba-Rodriguez R., Frucht D.M. IL-23 and IL-27: new members of the growing family of IL-12-related cytokines with important implications for therapeutics. Expert Opin Biol Ther 2003, 3:715-723.
46. Shimizu M., Shimamura M., Owaki T., Asakawa M., Fujita K., Kudo M., et al. Antiangiogenic and antitumor activities of IL-27. J Immunol 2006, 176:7317-7324.
47. Hisada M., Kamiya S., Fujita K., Belladonna M.L., Aoki T., Koyanagi Y., et al. Potent antitumor activity of interleukin-27. Cancer Res 2004, 64:1152-1156.
48. Miteva L., Stanilov N., Deliysky T., Mintchev N., Stanilova S. Association of polymorphisms in regulatory regions of interleukin-12p40 gene and cytokine serum level with colorectal cancer. Cancer Invest 2009, 27:924-931.
49. Zhao B., Meng L.Q., Huang H.N., Pan Y., Xu Q.Q. A novel functional polymorphism, 16974 A/C, in the interleukin-12-3' untranslated region is associated with risk of glioma. DNA Cell Biol 2009, 28:335-341.
50. Liu L., Xu Y., Liu Z., Chen J., Zhang Y., Zhu J., et al. IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population. Int J Cancer 2011, 128:1692-1696.
51. Smith L.M., Bonafonte M.T., Campbell L.D., Mead J.R. Exogenous interleukin-12 (IL-12) exacerbates Cryptosporidium parvum infection in gamma interferon knockout mice. Exp Parasitol 2001, 98:123-133.